XML 27 R61.htm IDEA: XBRL DOCUMENT v3.3.0.814
Supplemental Guarantor Financial Information (Consolidated Statements Of Cash Flows) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 31, 2015
Aug. 01, 2015
May. 02, 2015
Nov. 01, 2014
Aug. 02, 2014
May. 03, 2014
Oct. 31, 2015
Nov. 01, 2014
Net Cash Provided by Operating Activities             $ 262 $ 370
Investing Activities:                
Capital Expenditures             (603) (585)
Proceeds from Sale of Other Assets             196  
Proceeds from Sale of Equity Method Investments             85 0
Proceeds from Sale and Maturity of Marketable Securities             50 0
Payments to Acquire Marketable Securities             (60) 0
Other Investing Activities             0 15
Net Cash Provided by (Used for) Investing Activities             (332) (570)
Financing Activities:                
Proceeds from Debt, Net of Issuance Costs             988 0
Proceeds from Long-term Lines of Credit             0 5
Repayments of Long-term Lines of Credit             0 (5)
Repurchase of Common Stock             (363) (48)
Dividends Paid $ (146) $ (146) $ (734) $ (100) $ (99) $ (392) (1,026) (591)
Excess Tax Benefits from Share-based Compensation             65 41
Net Financing Activities and Advances to/from Consolidated Affiliates             0 0
Proceeds from Exercise of Stock Options             31 28
Proceeds from (Payments for) Other Financing Activities             3 (5)
Net Cash Provided by (Used for) Financing Activities             (302) (575)
Effects of Exchange Rate Changes on Cash and Cash Equivalents             2 1
Net Increase (Decrease) in Cash and Cash Equivalents             (370) (774)
Cash and Cash Equivalents, Beginning of Period     1,681     1,519 1,681 1,519
Cash and Cash Equivalents, End of Period 1,311     745     1,311 745
L Brands, Inc.                
Net Cash Provided by Operating Activities             (254) (260)
Investing Activities:                
Capital Expenditures             0 0
Proceeds from Sale of Other Assets             0  
Proceeds from Sale of Equity Method Investments             0  
Proceeds from Sale and Maturity of Marketable Securities             0  
Payments to Acquire Marketable Securities             0  
Other Investing Activities               0
Net Cash Provided by (Used for) Investing Activities             0 0
Financing Activities:                
Proceeds from Debt, Net of Issuance Costs             988  
Proceeds from Long-term Lines of Credit               0
Repayments of Long-term Lines of Credit               0
Repurchase of Common Stock             (363) (48)
Dividends Paid             (1,026) (591)
Excess Tax Benefits from Share-based Compensation             0 0
Net Financing Activities and Advances to/from Consolidated Affiliates             624 876
Proceeds from Exercise of Stock Options             31 28
Proceeds from (Payments for) Other Financing Activities             0 (5)
Net Cash Provided by (Used for) Financing Activities             254 260
Effects of Exchange Rate Changes on Cash and Cash Equivalents             0 0
Net Increase (Decrease) in Cash and Cash Equivalents             0 0
Cash and Cash Equivalents, Beginning of Period     0     0 0 0
Cash and Cash Equivalents, End of Period 0     0     0 0
Guarantor Subsidiaries                
Net Cash Provided by Operating Activities             377 457
Investing Activities:                
Capital Expenditures             (440) (426)
Proceeds from Sale of Other Assets             0  
Proceeds from Sale of Equity Method Investments             1  
Proceeds from Sale and Maturity of Marketable Securities             50  
Payments to Acquire Marketable Securities             (50)  
Other Investing Activities               0
Net Cash Provided by (Used for) Investing Activities             (439) (426)
Financing Activities:                
Proceeds from Debt, Net of Issuance Costs             0  
Proceeds from Long-term Lines of Credit               0
Repayments of Long-term Lines of Credit               0
Repurchase of Common Stock             0 0
Dividends Paid             0 0
Excess Tax Benefits from Share-based Compensation             57 35
Net Financing Activities and Advances to/from Consolidated Affiliates             (370) (903)
Proceeds from Exercise of Stock Options             0 0
Proceeds from (Payments for) Other Financing Activities             (2) 0
Net Cash Provided by (Used for) Financing Activities             (315) (868)
Effects of Exchange Rate Changes on Cash and Cash Equivalents             0 0
Net Increase (Decrease) in Cash and Cash Equivalents             (377) (837)
Cash and Cash Equivalents, Beginning of Period     1,462     1,353 1,462 1,353
Cash and Cash Equivalents, End of Period 1,085     516     1,085 516
Non- guarantor Subsidiaries                
Net Cash Provided by Operating Activities             139 173
Investing Activities:                
Capital Expenditures             (163) (159)
Proceeds from Sale of Other Assets             196  
Proceeds from Sale of Equity Method Investments             84  
Proceeds from Sale and Maturity of Marketable Securities             0  
Payments to Acquire Marketable Securities             (10)  
Other Investing Activities               15
Net Cash Provided by (Used for) Investing Activities             107 (144)
Financing Activities:                
Proceeds from Debt, Net of Issuance Costs             0  
Proceeds from Long-term Lines of Credit               5
Repayments of Long-term Lines of Credit               (5)
Repurchase of Common Stock             0 0
Dividends Paid             0 0
Excess Tax Benefits from Share-based Compensation             8 6
Net Financing Activities and Advances to/from Consolidated Affiliates             (254) 27
Proceeds from Exercise of Stock Options             0 0
Proceeds from (Payments for) Other Financing Activities             5 0
Net Cash Provided by (Used for) Financing Activities             (241) 33
Effects of Exchange Rate Changes on Cash and Cash Equivalents             2 1
Net Increase (Decrease) in Cash and Cash Equivalents             7 63
Cash and Cash Equivalents, Beginning of Period     219     166 219 166
Cash and Cash Equivalents, End of Period 226     229     226 229
Eliminations                
Net Cash Provided by Operating Activities             0 0
Investing Activities:                
Capital Expenditures             0 0
Proceeds from Sale of Other Assets             0  
Proceeds from Sale of Equity Method Investments             0  
Proceeds from Sale and Maturity of Marketable Securities             0  
Payments to Acquire Marketable Securities             0  
Other Investing Activities               0
Net Cash Provided by (Used for) Investing Activities             0 0
Financing Activities:                
Proceeds from Debt, Net of Issuance Costs             0  
Proceeds from Long-term Lines of Credit               0
Repayments of Long-term Lines of Credit               0
Repurchase of Common Stock             0 0
Dividends Paid             0 0
Excess Tax Benefits from Share-based Compensation             0 0
Net Financing Activities and Advances to/from Consolidated Affiliates             0 0
Proceeds from Exercise of Stock Options             0 0
Proceeds from (Payments for) Other Financing Activities             0 0
Net Cash Provided by (Used for) Financing Activities             0 0
Effects of Exchange Rate Changes on Cash and Cash Equivalents             0 0
Net Increase (Decrease) in Cash and Cash Equivalents             0 0
Cash and Cash Equivalents, Beginning of Period     $ 0     $ 0 0 0
Cash and Cash Equivalents, End of Period $ 0     $ 0     $ 0 $ 0